SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about board meeting

08 Dec 2017 Evaluate

Medicamen Biotech has informed that the Meeting of the Board of Directors of the Company will be held on Thursday the 14th day of December, 2017 at 2.00 p.m. at registered office of the Company to issue Equity Shares on Preferential Allotment basis to the promoter group and non promoter group, and to call an Extra Ordinary General Meeting.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

261.70 -5.50 (-2.06%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×